Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR was delisted on the 16th of April, 2019.
32 hedge funds and large institutions have $29.6M invested in Osiris Therapeutics, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
25,412% more capital invested
Capital invested by funds: $116K → $29.6M (+$29.5M)
3,100% more funds holding
Funds holding: 1 → 32 (+31)
3,100% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.15M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$6.42M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$4.61M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.37M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Public Employees Retirement Association of Colorado
Denver,
Colorado
|
-$116K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BlackRock
New York
| $11K | +$10K | +1,000 | New |
|
|
LTFS
27
Ladenburg Thalmann Financial Services
Miami,
Florida
| $6K | +$5K | +500 | New |
|
28
Morgan Stanley
New York
| $3K | +$2.5K | +250 | New |
|
29
Barclays
London,
United Kingdom
| $2K | +$1.47K | +147 | New |
|
|
VFA
30
Valeo Financial Advisors
Carmel,
Indiana
| $2K | +$2.34K | +234 | New |
|
31
Group One Trading
Chicago,
Illinois
| $1K | +$660 | +66 | New |
|
|
FGAM
32
Financial Gravity Asset Management
Lakeway,
Texas
| $1K | +$680 | +68 | New |
|
|
AG
33
Advisor Group
Phoenix,
Arizona
| $1K | +$1.1K | +110 | New |
|
|
34
Public Employees Retirement Association of Colorado
Denver,
Colorado
| – | -$116K | -11,982 | Closed |
|
OSIR Hedge Fund Activity: Q3 2018 in Review
32 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q3 2018, worth a combined $29.6M — up 25,412% from $116K a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new OSIR positions and 1 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $7.15M. The largest seller was Public Employees Retirement Association of Colorado, exiting entirely with an estimated $116K sold.
- 32 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q3 2018, up from 1 in Q2 2018.
- Funds reported $29.6M of Osiris Therapeutics, Inc. Common Stock stock for Q3 2018, up 25,412% quarter-over-quarter.
- 32 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q3 2018 and 1 closed out, a net change of +31 holders.
- The largest Osiris Therapeutics, Inc. Common Stock buyer in Q3 2018 was Vanguard Group, an estimated $7.15M added.
- The largest Osiris Therapeutics, Inc. Common Stock seller in Q3 2018 was Public Employees Retirement Association of Colorado, an estimated $116K sold.
Based on aggregated 13F filings for Q3 2018.